Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Veterinary/Animal Vaccines Market

ID: MRFR/Pharma/16503-HCR
100 Pages
Satyendra Maurya
Last Updated: April 06, 2026

US Veterinary Animal Vaccines Market Research Report By Type (Livestock Vaccines, Porcine Vaccines) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Veterinary/Animal Vaccines Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Food, Beverages & Nutrition, BY Type (USD Million)
  49.     4.1.1 Porcine Vaccines
  50.     4.1.2 Poultry Vaccine
  51.     4.1.3 Livestock Vaccine
  52.     4.1.4 Bovine Vaccines
  53.     4.1.5 Small Ruminant Vaccines
  54.     4.1.6 Companion Animal Vaccine
  55.     4.1.7 Canine Vaccine
  56.     4.1.8 Feline Vaccine
  57.     4.1.9 Aquaculture Vaccines
  58.     4.1.10 Other Animal Vaccines
  59.   4.2 Food, Beverages & Nutrition, BY Disease (USD Million)
  60.     4.2.1 Porcine
  61.     4.2.2 Poultry
  62.     4.2.3 Livestock
  63.     4.2.4 Bovine
  64.     4.2.5 Small Ruminant
  65.     4.2.6 Companion Animal
  66.     4.2.7 Canine
  67.     4.2.8 Feline
  68.     4.2.9 Aquaculture
  69.   4.3 Food, Beverages & Nutrition, BY Technology (USD Million)
  70.     4.3.1 Live Attenuated Vaccines
  71.     4.3.2 Inactivated Vaccines
  72.     4.3.3 Toxoid Vaccines
  73.     4.3.4 Recombinant Vaccines
  74.     4.3.5 Other Vaccines
  75. 5 SECTION V: COMPETITIVE ANALYSIS
  76.   5.1 Competitive Landscape
  77.     5.1.1 Overview
  78.     5.1.2 Competitive Analysis
  79.     5.1.3 Market share Analysis
  80.     5.1.4 Major Growth Strategy in the Food, Beverages & Nutrition
  81.     5.1.5 Competitive Benchmarking
  82.     5.1.6 Leading Players in Terms of Number of Developments in the Food, Beverages & Nutrition
  83.     5.1.7 Key developments and growth strategies
  84.       5.1.7.1 New Product Launch/Service Deployment
  85.       5.1.7.2 Merger & Acquisitions
  86.       5.1.7.3 Joint Ventures
  87.     5.1.8 Major Players Financial Matrix
  88.       5.1.8.1 Sales and Operating Income
  89.       5.1.8.2 Major Players R&D Expenditure. 2023
  90.   5.2 Company Profiles
  91.     5.2.1 Zoetis (US)
  92.       5.2.1.1 Financial Overview
  93.       5.2.1.2 Products Offered
  94.       5.2.1.3 Key Developments
  95.       5.2.1.4 SWOT Analysis
  96.       5.2.1.5 Key Strategies
  97.     5.2.2 Merck Animal Health (US)
  98.       5.2.2.1 Financial Overview
  99.       5.2.2.2 Products Offered
  100.       5.2.2.3 Key Developments
  101.       5.2.2.4 SWOT Analysis
  102.       5.2.2.5 Key Strategies
  103.     5.2.3 Boehringer Ingelheim (DE)
  104.       5.2.3.1 Financial Overview
  105.       5.2.3.2 Products Offered
  106.       5.2.3.3 Key Developments
  107.       5.2.3.4 SWOT Analysis
  108.       5.2.3.5 Key Strategies
  109.     5.2.4 Elanco Animal Health (US)
  110.       5.2.4.1 Financial Overview
  111.       5.2.4.2 Products Offered
  112.       5.2.4.3 Key Developments
  113.       5.2.4.4 SWOT Analysis
  114.       5.2.4.5 Key Strategies
  115.     5.2.5 Virbac (FR)
  116.       5.2.5.1 Financial Overview
  117.       5.2.5.2 Products Offered
  118.       5.2.5.3 Key Developments
  119.       5.2.5.4 SWOT Analysis
  120.       5.2.5.5 Key Strategies
  121.     5.2.6 Ceva Santé Animale (FR)
  122.       5.2.6.1 Financial Overview
  123.       5.2.6.2 Products Offered
  124.       5.2.6.3 Key Developments
  125.       5.2.6.4 SWOT Analysis
  126.       5.2.6.5 Key Strategies
  127.     5.2.7 Heska Corporation (US)
  128.       5.2.7.1 Financial Overview
  129.       5.2.7.2 Products Offered
  130.       5.2.7.3 Key Developments
  131.       5.2.7.4 SWOT Analysis
  132.       5.2.7.5 Key Strategies
  133.     5.2.8 Vetoquinol (FR)
  134.       5.2.8.1 Financial Overview
  135.       5.2.8.2 Products Offered
  136.       5.2.8.3 Key Developments
  137.       5.2.8.4 SWOT Analysis
  138.       5.2.8.5 Key Strategies
  139.   5.3 Appendix
  140.     5.3.1 References
  141.     5.3.2 Related Reports
  142. 6 LIST OF FIGURES
  143.   6.1 MARKET SYNOPSIS
  144.   6.2 US MARKET ANALYSIS BY TYPE
  145.   6.3 US MARKET ANALYSIS BY DISEASE
  146.   6.4 US MARKET ANALYSIS BY TECHNOLOGY
  147.   6.5 KEY BUYING CRITERIA OF FOOD, BEVERAGES & NUTRITION
  148.   6.6 RESEARCH PROCESS OF MRFR
  149.   6.7 DRO ANALYSIS OF FOOD, BEVERAGES & NUTRITION
  150.   6.8 DRIVERS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
  151.   6.9 RESTRAINTS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
  152.   6.10 SUPPLY / VALUE CHAIN: FOOD, BEVERAGES & NUTRITION
  153.   6.11 FOOD, BEVERAGES & NUTRITION, BY TYPE, 2024 (% SHARE)
  154.   6.12 FOOD, BEVERAGES & NUTRITION, BY TYPE, 2024 TO 2035 (USD Million)
  155.   6.13 FOOD, BEVERAGES & NUTRITION, BY DISEASE, 2024 (% SHARE)
  156.   6.14 FOOD, BEVERAGES & NUTRITION, BY DISEASE, 2024 TO 2035 (USD Million)
  157.   6.15 FOOD, BEVERAGES & NUTRITION, BY TECHNOLOGY, 2024 (% SHARE)
  158.   6.16 FOOD, BEVERAGES & NUTRITION, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
  159.   6.17 BENCHMARKING OF MAJOR COMPETITORS
  160. 7 LIST OF TABLES
  161.   7.1 LIST OF ASSUMPTIONS
  162.     7.1.1
  163.   7.2 US MARKET SIZE ESTIMATES; FORECAST
  164.     7.2.1 BY TYPE, 2025-2035 (USD Million)
  165.     7.2.2 BY DISEASE, 2025-2035 (USD Million)
  166.     7.2.3 BY TECHNOLOGY, 2025-2035 (USD Million)
  167.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  168.     7.3.1
  169.   7.4 ACQUISITION/PARTNERSHIP
  170.     7.4.1

US Food, Beverages & Nutrition Market Segmentation

Food, Beverages & Nutrition By Type (USD Million, 2025-2035)

  • Porcine Vaccines
  • Poultry Vaccine
  • Livestock Vaccine
  • Bovine Vaccines
  • Small Ruminant Vaccines
  • Companion Animal Vaccine
  • Canine Vaccine
  • Feline Vaccine
  • Aquaculture Vaccines
  • Other Animal Vaccines

Food, Beverages & Nutrition By Disease (USD Million, 2025-2035)

  • Porcine
  • Poultry
  • Livestock
  • Bovine
  • Small Ruminant
  • Companion Animal
  • Canine
  • Feline
  • Aquaculture

Food, Beverages & Nutrition By Technology (USD Million, 2025-2035)

  • Live Attenuated Vaccines
  • Inactivated Vaccines
  • Toxoid Vaccines
  • Recombinant Vaccines
  • Other Vaccines

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓